Jiangsu Yongjian Medical Technology Co., Ltd
Established in March 2012, Jiangsu Yongjian Pharmaceutical Technology Co., Ltd. is located in China Pharmaceutical City, Taizhou City, Jiangsu Province. It is a national high-tech enterprise specializing in the research and development of active ingredients of natural products, providing the physical supply of chemical reference substances of traditional Chinese medicine and the material basis research of traditional Chinese medicine.
So far, the company has conducted in-depth research on more than 100 kinds of commonly used traditional Chinese medicines, extracted more than 1000 kinds of chemical components from them, and provided them to the National Institute for drug control, pharmaceutical factories, decoction pieces factories and hundreds of scientific research institutions at home and abroad as detection reagents and raw materials for new drug research and development.
Over the years, the company has undertaken and completed a number of national, provincial and municipal science and technology projects, and many people have been selected into the doctor gathering plan of Jiangsu Province, "333 high-level talent training project" of Jiangsu Province, and "113 special talent plan" of China Pharmaceutical City, high-level innovation and Entrepreneurship Talent Plan, etc.
In recent years, the company has made major breakthroughs in the research and development of new drugs in traditional Chinese medicine, purified a number of highly active monomer compounds from commonly used traditional Chinese medicine, and authorized a number of domestic and international patents. The research and development of new drugs is advancing in an orderly manner.
The company's advantageous business scope:
R & D, production and sales of chemical reference materials of traditional Chinese Medicine
Customized Chinese medicine monomer compounds according to customer characteristics
Study on quality standard and technology of Chinese herbal (plant) extract
Technology cooperation, transfer and new drug research and development